Medipattern, a developer of computer-aided detection (CAD) medical imaging software, has received State FDA (SFDA) approval in China for its B-CAD product.

Beijing Eastwide, Medipattern’s reseller in China, assisted the company in submitting B-CAD for SFDA approval and will promote and market B-CAD throughout mainland China, according to the Toronto-based Medipattern.

The company said that its B-CAD is installed and now in daily use at the new Breast Imaging Center at the People's Liberation Army 301 Hospital, China's premier hospital and research center in Beijing.